Literature DB >> 11529932

The regulation of FasL expression during activation-induced cell death (AICD).

T Nguyen1, J Russell.   

Abstract

Activation-induced cell death (AICD), a Fas ligand (FasL)-dependent pathway, is important for maintaining T-cell homeostasis. Interleukin-2 (IL-2), an enhancer of AICD, can also enhance FasL expression. However, we show that the level of FasL or FLIP protein did not correlate with the susceptibility to AICD. Some T cells expressed high levels of FasL yet failed to undergo AICD, while others expressed little FasL and were sensitive. AICD susceptibility did not correlate with the kinetics of FasL up-regulation or down-regulation. The down-regulation of FasL can be mediated by a metalloprotease. However, we describe an alternative mechanism for the loss of FasL by endocytosis. Endocytosis inhibitors such as cytochalasins, sodium azide, deoxyglucose, or low temperatures prevented the loss of FasL. KB8301, a metalloprotease inhibitor had no effect on the loss of FasL or AICD in the T cells. Enhancing FasL expression was not crucial for AICD and the down-regulation of FasL proceeded via endocytosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11529932      PMCID: PMC1783263          DOI: 10.1046/j.1365-2567.2001.01264.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  42 in total

1.  Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape.

Authors:  N P Restifo
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

Review 2.  Apoptosis and CD95 ligand in immune privileged sites.

Authors:  D Bellgrau; R C Duke
Journal:  Int Rev Immunol       Date:  1999       Impact factor: 5.311

3.  CD4+ T lymphocyte-induced target cell detachment. A model for T cell-mediated lytic and nonlytic inflammatory processes.

Authors:  S I Abrams; J H Russell
Journal:  J Immunol       Date:  1991-01-15       Impact factor: 5.422

4.  CD95-dependent bystander lysis caused by CD4+ T helper 1 effectors.

Authors:  R Wang; A M Rogers; T L Ratliff; J H Russell
Journal:  J Immunol       Date:  1996-10-01       Impact factor: 5.422

Review 5.  Immune privilege or inflammation? The paradoxical effects of Fas ligand.

Authors:  J O'Connell
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2000       Impact factor: 4.291

6.  Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes.

Authors:  L Ottonello; G Tortolina; M Amelotti; F Dallegri
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

7.  Overexpression of Fas ligand does not confer immune privilege to a pancreatic beta tumor cell line (betaTC-3).

Authors:  S Okamoto; S Takamizawa; W Bishop; J Wen; K Kimura; A Sandler
Journal:  J Surg Res       Date:  1999-06-01       Impact factor: 2.192

8.  Cutting edge: the tumor counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway.

Authors:  N Favre-Felix; A Fromentin; A Hammann; E Solary; F Martin; B Bonnotte
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

Review 9.  The role of placental Fas ligand in maintaining immune privilege at maternal-fetal interfaces.

Authors:  S Guller; L LaChapelle
Journal:  Semin Reprod Endocrinol       Date:  1999

10.  Expression of the functional soluble form of human fas ligand in activated lymphocytes.

Authors:  M Tanaka; T Suda; T Takahashi; S Nagata
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598

View more
  12 in total

1.  Increased spontaneous ex vivo apoptosis and subset alterations in peripheral blood T cells from patients with multiple sclerosis.

Authors:  Alfredo Prieto; David Díaz; Hugo Barcenilla; Carmen Castrillo; Jorge Monserrat; Antonio García Merino; Melchor Alvarez-Mon
Journal:  J Clin Immunol       Date:  2006-05-02       Impact factor: 8.317

2.  Comparative analyses of differentially induced T-cell receptor-mediated phosphorylation pathways in T lymphoma cells.

Authors:  Serina Ortiz; Wenhui Lee; David Smith; Stephen J Forman; Terry D Lee; Chih-Pin Liu
Journal:  Exp Biol Med (Maywood)       Date:  2010-12

3.  The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases.

Authors:  D S Vinay; B S Kwon
Journal:  Clin Exp Immunol       Date:  2011-03-14       Impact factor: 4.330

4.  Antigen-driven T-cell selection in patients with cervical cancer as evidenced by T-cell receptor analysis and recognition of autologous tumor.

Authors:  H Pilch; H Höhn; C Neukirch; K Freitag; P G Knapstein; B Tanner; M J Maeurer
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

5.  Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy.

Authors:  Inja Waldhauer; Valeria Gonzalez-Nicolini; Anne Freimoser-Grundschober; Tapan K Nayak; Linda Fahrni; Ralf J Hosse; Danny Gerrits; Edwin J W Geven; Johannes Sam; Sabine Lang; Esther Bommer; Virginie Steinhart; Elisabeth Husar; Sara Colombetti; Erwin Van Puijenbroek; Markus Neubauer; J Mark Cline; Pradeep K Garg; Gregory Dugan; Federica Cavallo; Gonzalo Acuna; Jehad Charo; Volker Teichgräber; Stefan Evers; Otto C Boerman; Marina Bacac; Ekkehard Moessner; Pablo Umaña; Christian Klein
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

6.  Negative autoregulation by Fas stabilizes adult erythropoiesis and accelerates its stress response.

Authors:  Miroslav Koulnis; Ying Liu; Kelly Hallstrom; Merav Socolovsky
Journal:  PLoS One       Date:  2011-07-08       Impact factor: 3.240

7.  FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.

Authors:  Tong Sun; Yifeng Zhou; Hua Li; Xiaohong Han; Yuankai Shi; Li Wang; Xiaoping Miao; Wen Tan; Dan Zhao; Xuemei Zhang; Yongli Guo; Dongxin Lin
Journal:  J Exp Med       Date:  2005-09-26       Impact factor: 14.307

8.  Four Cysteine Residues Contribute to Homodimerization of Chicken Interleukin-2.

Authors:  Chen Deng; Hailiang Tan; Hongda Zhou; Mengyun Wang; Yan Lü; Jiacui Xu; Huanmin Zhang; Limei Han; Yongxing Ai
Journal:  Int J Mol Sci       Date:  2019-11-15       Impact factor: 5.923

9.  Mitomycin C induces bystander killing in homogeneous and heterogeneous hepatoma cellular models.

Authors:  Ratna Kumari; Aanchal Sharma; Amrendra Kumar Ajay; Manoj Kumar Bhat
Journal:  Mol Cancer       Date:  2009-10-21       Impact factor: 27.401

10.  The Immunopathobiology of SARS-CoV-2 Infection.

Authors:  Milankumar Patel; Farah Shahjin; Jacob D Cohen; Mahmudul Hasan; Jatin Machhi; Heerak Chugh; Snigdha Singh; Srijanee Das; Tanmay A Kulkarni; Jonathan Herskovitz; Douglas D Meigs; Ramesh Chandra; Kenneth S Hettie; R Lee Mosley; Bhavesh D Kevadiya; Howard E Gendelman
Journal:  FEMS Microbiol Rev       Date:  2021-11-23       Impact factor: 16.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.